Profile
Kurt W.
Leutzinger served as the Chief Financial Officer at Abgenix, Inc. from 1997 to 2004, and as the Chief Financial Officer & Executive Vice President at Pharmasset, Inc. from 2005 to 2012.
Prior to that, he worked as a Private Equity Portfolio Manager at GE Asset Management, Inc. from 1987 to 1997.
Leutzinger received his undergraduate degree from Fairleigh Dickinson University and his MBA from New York University.
Former positions of Kurt W. Leutzinger
| Companies | Position | End |
|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Director of Finance/CFO | 12/01/2012 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Director of Finance/CFO | 31/12/2003 |
GE Asset Management, Inc. (Private Equity)
 GE Asset Management, Inc. (Private Equity) Investment ManagersFinance GE Asset Management Inc. (Private Equity) is a private equity subsidiary of GE Asset Management Inc. The firm is founded in 1988 and located in Connecticut, New York. | Corporate Officer/Principal | 31/12/1996 |
Training of Kurt W. Leutzinger
| Fairleigh Dickinson University | Undergraduate Degree |
| New York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
GE Asset Management, Inc. (Private Equity)
GE Asset Management, Inc. (Private Equity) Investment ManagersFinance GE Asset Management Inc. (Private Equity) is a private equity subsidiary of GE Asset Management Inc. The firm is founded in 1988 and located in Connecticut, New York. | Finance |
- Stock Market
- Insiders
- Kurt W. Leutzinger